CN102626506B - Traditional Chinese medicine for curing seroperitoneum - Google Patents
Traditional Chinese medicine for curing seroperitoneum Download PDFInfo
- Publication number
- CN102626506B CN102626506B CN 201210116846 CN201210116846A CN102626506B CN 102626506 B CN102626506 B CN 102626506B CN 201210116846 CN201210116846 CN 201210116846 CN 201210116846 A CN201210116846 A CN 201210116846A CN 102626506 B CN102626506 B CN 102626506B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- semen
- seroperitoneum
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 40
- 210000000582 semen Anatomy 0.000 claims abstract description 53
- 239000002994 raw material Substances 0.000 claims description 21
- 241000407170 Curcuma Species 0.000 claims description 12
- 235000014375 Curcuma Nutrition 0.000 claims description 12
- 241000208966 Polygala Species 0.000 claims description 12
- 241000545442 Radix Species 0.000 claims description 12
- 241000233948 Typha Species 0.000 claims description 12
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 5
- 229940126678 chinese medicines Drugs 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 17
- 210000000952 spleen Anatomy 0.000 abstract description 14
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 230000004087 circulation Effects 0.000 abstract description 4
- 230000001914 calming effect Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241001080798 Polygala tenuifolia Species 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 210000005036 nerve Anatomy 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 230000008961 swelling Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000000843 powder Substances 0.000 description 10
- 230000003187 abdominal effect Effects 0.000 description 7
- 239000012467 final product Substances 0.000 description 7
- 210000001015 abdomen Anatomy 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 210000001835 viscera Anatomy 0.000 description 5
- 239000002775 capsule Substances 0.000 description 4
- 239000002934 diuretic Substances 0.000 description 4
- 230000001882 diuretic effect Effects 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000011218 segmentation Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 206010016766 flatulence Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000001113 umbilicus Anatomy 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 239000003390 Chinese drug Substances 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000010482 emotional regulation Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 208000013210 hematogenous Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
- 239000008843 wulingsan Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for curing seroperitoneum, which is prepared with the following materials based on parts by weight: 12-18 parts of semen coicis, 12-18 parts of radix angelicae, 12-18 parts of cortex dictamni, 12-18 parts of pollen typhae, 12-18 parts of angelica sinensis, 12-18 parts of ligusticum wallichii, 12-18 parts of root of common peony, 12-18 parts of peach seed, 12-18 parts of spina date seed, 12-18 parts of platycladi seed, 12-18 parts of polygala tenuifolia, 12-18 parts of radix curcumae and 8-15 parts of liquorice. All herbs in the traditional Chinese medicine for curing seroperitoneum are harmonized in coordination, and jointly play the roles of invigorating spleen and supplementing qi, promoting circulation and removing stasis, clearing heat and dispersing swelling, and nourishing the heart and calming the nerves. Total effective rate of curing reaches 97%. Besides, cost is low and no toxic and side effects are found.
Description
Technical field
The present invention relates to a kind of Chinese medicine that is used for the treatment of seroperitoneum.
Background technology
The cause of disease Chang Yinwei peritonitis of seroperitoneum, pelvic inflammatory disease etc. or abdominal postoperative inflammation cause, also can be by the liver spleen kidney three dirty disease that are subjected to, cause that the stasis of bloods such as gas, blood, water amass in abdomen, and day by day swell to see abdominal part, form tympanites.Seroperitoneum is controlled difficult for a long time, repeatedly outbreak, severe patient entail dangers to life.Exopathogenic factor, endogenous cause of ill two aspects are arranged, and endogenous cause of ill mainly is damaged by excess of seven emotions, outer because heresy and the eating and drinking without temperance of six climate exopathogens, and the heresy of six climate exopathogens, damp and hot such as diseases caused by exogenous pathogenic factor, from outward appearance to inner essence strongly fragrant and do not reach, Jiao or the part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels in the internal resistance can not be let out more.If have a liking for product pungent or the delicious food savoury, every energy impairing the spleen and stomach causes the transportation capabilities dereliction of duty, endogenous damp formation; Feelings will is hindered, or the hyperamization stasis of blood, or horizontal criminal's taste, water-damp retention, and damp is strongly fragrant for a long time all can heat-transformation.Therefore, damp-heat accumulation is the initiating agent of seroperitoneum, damp and hotly violates firstly at taste, is obstructed to mechanism of qi eventually, and hematogenous blockage, water must not be let out and form tympanites.The multiplex clearing away heat-damp and promoting diuresis method of clinical treatment.Seroperitoneum is also relevant with blood stasis, though seroperitoneum sick at water and the source at blood, i.e. menstruation disorder and be water.Blood circulation promoting and blood stasis dispelling is significant in therapeutic process, and blood circulation promoting and blood stasis dispelling makes QI-blood circulation unobstructed, and not only the foster state of internal organs mistake is eased, and also can make the efficacy of a drug arrive smoothly disease institute.Qi being the governor of blood, all diet precise and tiny, the waste matter of conversion all depends on the defeated cloth of gas, causes in gas, blood, the water alluvial abdomen and zang-fu organs qi movement is unfavorable, so harmonizing the functional activities of vital QI in the treatment is the prerequisite of blood stasis dispelling and diuretic.The temper virtual loss is the inherent pathologic basis of seroperitoneum, and the patient of seroperitoneum all has the symptom of spleen and stomach: poor appetite, feel sick, vomiting, limbs fatigue, distension and fullness in the abdomen, diarrhoea borborygmus etc.Clinical treatment is main mainly with removing dampness and diuretic medicine, such as the drink of the tonifying the spleen in the recipes for Saving Lives, the WULING SAN in the treatise on Febrile Diseases, three Hua Shen Yu balls in " Xuanming Lun Fang, Clear Synopsis on Recipes " etc.
Heat clearing away, invigorate blood circulation, circulation of qi promoting, diuretic be the method for taking stopgap measures, and invigorating the spleen and benefiting QI, strengthening the spleen to restrain water side are the methods of effecting a permanent cure.In addition, tranquilizing by nourishing the heart, arresting sweating detumescence also are the cardinal principle for the treatment of, also should pay attention to nursing one's health diet feelings will.The Chinese medicine that is used for the treatment of seroperitoneum of the present invention is exactly according to above Therapeutic Principle, the Chinese medicine preparation of meticulously selecting raw material components and proportioning to make.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine that is used for the treatment of seroperitoneum.
The objective of the invention is to realize by following technical proposals:
According to the Chinese medicine that is used for the treatment of seroperitoneum of the present invention, it is characterized in that it comprises the raw material components of following weight portion proportioning:
12～18 parts of Semen Coiciss, 12～18 parts of the Radixs Angelicae Dahuricae, 12～18 parts of Cortex Dictamni, 12～18 parts of Pollen Typhaes, 12～18 parts of Radix Angelicae Sinensis, 12～18 parts of Rhizoma Chuanxiongs, 12～18 parts of Radix Paeoniae Rubra, 12～18 parts in Semen Persicae, 12～18 parts of Semen Ziziphi Spinosaes, 12～18 parts of Semen Platycladi, 12～18 parts of Radix Polygalaes, 12～18 parts of Radix Curcumaes, 8～15 parts in Radix Glycyrrhizae.
According to the Chinese medicine that is used for the treatment of seroperitoneum of the present invention, it is characterized in that it also comprises the raw material components of following weight portion proportioning:
12～18 parts of the Rhizoma Atractylodis Macrocephalaes, 8～15 parts in Poria.
According to the Chinese medicine that is used for the treatment of seroperitoneum of the present invention, it is characterized in that it is that raw material components by following weight portion proportioning consists of:
13～16 parts of Semen Coiciss, 13～16 parts of the Radixs Angelicae Dahuricae, 13～16 parts of Cortex Dictamni, 13～16 parts of Pollen Typhaes, 13～16 parts of Radix Angelicae Sinensis, 13～16 parts of Rhizoma Chuanxiongs, 13～16 parts of Radix Paeoniae Rubra, 13～16 parts in Semen Persicae, 13～16 parts of Semen Ziziphi Spinosaes, 13～16 parts of Semen Platycladi, 13～16 parts of Radix Polygalaes, 13～16 parts of Radix Curcumaes,, 8～12 parts in Radix Glycyrrhizae.
According to the Chinese medicine that is used for the treatment of seroperitoneum of the present invention, it is characterized in that it is that raw material components by following weight portion proportioning consists of:
13～16 parts of Semen Coiciss, 13～16 parts of the Radixs Angelicae Dahuricae, 13～16 parts of Cortex Dictamni, 13～16 parts of Pollen Typhaes, 13～16 parts of Radix Angelicae Sinensis, 13～16 parts of Rhizoma Chuanxiongs, 13～16 parts of Radix Paeoniae Rubra, 13～16 parts in Semen Persicae, 13～16 parts of Semen Ziziphi Spinosaes, 13～16 parts of Semen Platycladi, 13～16 parts of Radix Polygalaes, 13～16 parts of Radix Curcumaes,, 8～12 parts in Radix Glycyrrhizae, 13～16 parts of the Rhizoma Atractylodis Macrocephalaes, 8～12 parts in Poria.
According to the Chinese medicine that is used for the treatment of seroperitoneum of the present invention, it is characterized in that it is that raw material components by following weight portion proportioning consists of:
15 parts of Semen Coiciss, 15 parts of the Radixs Angelicae Dahuricae, 15 parts of Cortex Dictamni, 15 parts of Pollen Typhaes, 15 parts of Radix Angelicae Sinensis, 15 parts of Rhizoma Chuanxiongs, 15 parts of Radix Paeoniae Rubra, 15 parts in Semen Persicae, 15 parts of Semen Ziziphi Spinosaes, 15 parts of Semen Platycladi, 15 parts of Radix Polygalaes, 15 parts of Radix Curcumaes, 10 parts in Radix Glycyrrhizae.
According to the Chinese medicine that is used for the treatment of seroperitoneum of the present invention, it is characterized in that it is that raw material components by following weight portion proportioning consists of:
15 parts of Semen Coiciss, 15 parts of the Radixs Angelicae Dahuricae, 15 parts of Cortex Dictamni, 15 parts of Pollen Typhaes, 15 parts of Radix Angelicae Sinensis, 15 parts of Rhizoma Chuanxiongs, 15 parts of Radix Paeoniae Rubra, 15 parts in Semen Persicae, 15 parts of Semen Ziziphi Spinosaes, 15 parts of Semen Platycladi, 15 parts of Radix Polygalaes, 15 parts of Radix Curcumaes, 10 parts in Radix Glycyrrhizae, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts in Poria.
The described Chinese medicine that is used for the treatment of seroperitoneum is characterized in that, wherein adds pharmaceutically acceptable carrier and makes and be suitable for medicinal preparation.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage forms, be prepared into any oral formulations commonly used such as disintegrating agent, lubricant, binding agent etc. with the method for Chinese medicinal of routine, such as being: pill, capsule, tablet, powder, granule or oral liquid etc.
The Chinese powder medicine preparation method for the treatment of seroperitoneum: with each raw material of above-mentioned weight, respectively drying and crushing to 120 order segmentation after whole powder components being mixed in described ratio, was sterilized under 100～120 ℃ 10～30 minutes, and be get final product.
The By Chinese Medicines agent for the treatment of seroperitoneum: each raw material of above-mentioned weight is mixed, after decocting for three times, three filtrates are mixed, filter, be concentrated into the concentration of regulation, let cool, the stock solution embedding, irradiation sterilization, after the check, packed products is made solution and be get final product.
The inventor has selected Semen Coicis: have the effect of spleen invigorating eliminating dampness by diuresis, clearing heat for detumescence, selected the Radix Angelicae Dahuricae: have the effect of removing damp and stopping pain, detumescence and apocenosis, as monarch drug through for many years experimentation;
Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae Rubra, Semen Persicae, Radix Curcumae have been selected: have the effect of blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain, as ministerial drug;
Selected Pollen Typhae: have the effect of hemostasia and dissipation blood stasis, treating stranguria pain relieving, selected Cortex Dictamni: the effect that has heat clearing and damp drying, dispels the wind and detoxify, as adjuvant drug;
Semen Ziziphi Spinosae, Semen Platycladi, Radix Polygalae have been selected: have the effect emotion regulation of tranquilizing by nourishing the heart, arresting sweating detumescence, selected Radix Glycyrrhizae: have the effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription, as making medicine;
For more serious seroperitoneum, also selected the Rhizoma Atractylodis Macrocephalae: the effect with invigorating the spleen and benefiting QI, dampness diuretic, selected Poria: the effect with spleen invigorating mind calming, promoting diuresis to eliminate damp pathogen, make it medicine as assistant, it is basic to control it, the Rhizoma Atractylodis Macrocephalae is the key medicine of tonifying the spleen and stomach, and spleen Tu Wang then clearing heat in QI system rises and on precise and tiny, and foul smell is fallen and waste matter is defeated.
Of the present invention in the Chinese medicine for the treatment of seroperitoneum, each Chinese medicine cooperation, the effect of playing altogether invigorating the spleen and benefiting QI, blood circulation promoting and blood stasis dispelling, clearing heat for detumescence, tranquilizing by nourishing the heart.
The specific embodiment
The invention will be further described below in conjunction with embodiment.
Embodiment 1: the raw material components by following weight consists of:
15 parts of Semen Coiciss, 15 parts of the Radixs Angelicae Dahuricae, 15 parts of Cortex Dictamni, 15 parts of Pollen Typhaes, 15 parts of Radix Angelicae Sinensis, 15 parts of Rhizoma Chuanxiongs, 15 parts of Radix Paeoniae Rubra, 15 parts in Semen Persicae, 15 parts of Semen Ziziphi Spinosaes, 15 parts of Semen Platycladi, 15 parts of Radix Polygalaes, 15 parts of Radix Curcumaes, 10 parts in Radix Glycyrrhizae.
Embodiment 2: the raw material components by following weight consists of:
15 parts of Semen Coiciss, 15 parts of the Radixs Angelicae Dahuricae, 15 parts of Cortex Dictamni, 15 parts of Pollen Typhaes, 15 parts of Radix Angelicae Sinensis, 15 parts of Rhizoma Chuanxiongs, 15 parts of Radix Paeoniae Rubra, 15 parts in Semen Persicae, 15 parts of Semen Ziziphi Spinosaes, 15 parts of Semen Platycladi, 15 parts of Radix Polygalaes, 15 parts of Radix Curcumaes, 10 parts in Radix Glycyrrhizae, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts in Poria.
The preparation method of embodiment 1～2:
The Chinese powder medicine for the treatment of seroperitoneum: with each raw material of above-mentioned weight, respectively drying and crushing to 120 order segmentation after whole powder components being mixed in described ratio, was sterilized under 110 ℃ 20 minutes, and be get final product.
The Chinese medicine capsules for the treatment of seroperitoneum: above-mentioned powder is incapsulated and get final product.
The Chinese medicine granules for the treatment of seroperitoneum: above-mentioned powder is added ethanol do binding agent, add starch and do filler, be pressed into granule.
The Chinese medicinal tablet for the treatment of seroperitoneum: each raw material of above-mentioned weight is mixed, after being ground into fine powder and crossing 100 order dusting covers, make tablet and get final product.
The medicine pill for the treatment of seroperitoneum: each raw material of above-mentioned weight is mixed, be ground into cross 80 mesh sieves behind the fine powder after, make pill and get final product.
The By Chinese Medicines agent for the treatment of seroperitoneum: each raw material of above-mentioned weight is mixed, after decocting for three times, three filtrates are mixed, filter, be concentrated into the concentration of regulation, let cool, the stock solution embedding, irradiation sterilization, after the check, packed products is made solution and be get final product.
The present invention treats the Clinical Action of Traditional Chinese Drugs of seroperitoneum and observes:
Physical data: adopt drug composition of the present invention to treat altogether 36 routine patients, male 19 examples wherein, women 17 examples; The oldest person 75 years old, the age reckling only has 22 years old.Disease as seen, abdominal part swells, from the beginning of the softness of pressing, gradually hard, very then venation appears, the acromphalus projection, shallow complexion, or gradually see dark, or two orders jaundice, the face cephalothorax has red point or the blood streak, loss of appetite, the food aftersensation is swollen, the lower long-pending piece distending pain of association, constipation or loose stool, oliguria.The enlarged abdomen that has is not hard, tense abdomen, the lower distension of the side of body or pain; The enlarged abdomen distension that has, by wrap up in water such as capsule, breast wrist feeling of distension and oppression etc.
Therapeutic Method:
Usage and dosage: dosage of the present invention depends on concrete dosage form, the factors such as patient age, body weight, health status.As guidance: for oral administration: 1) capsule: every day three times, each serving 2 one 5,0.5 part of every content of dispersion, warm water takes.2) tablet: every day three times, each 2 one 4,0.5 part of every content of dispersion, warm water takes.3) pill: every day three times, each 5 parts, warm water takes.4) granule: every day three times, each 5 parts, warm water takes.Solution: every day three times, each 10 milliliters.
The segmentation of powder with vinegar or yellow wine furnishing unguentum, is made and pasted the umbilicus agent, and auxiliary above-mentioned oral medicine should have better effects if.
The course for the treatment of: one month is a course for the treatment of, treats altogether the 1-3 course for the treatment of.
The standard of curative effect evaluation: cure: seroperitoneum disappears, and the abdominal viscera functional rehabilitation is normal, and each index of correlation reaches normal level, and sign is improved fully, and the patient is without any bad sensation.
Produce effects: seroperitoneum disappears substantially, and the abdominal viscera function approaches normal, and each index of correlation is near normal level, and sign is improved substantially, and the patient is substantially without any bad sensation.
Effectively: seroperitoneum is improved, and the abdominal viscera function is recovered to some extent, and each index of correlation reaches and makes moderate progress, and sign is improved.
Invalid: seroperitoneum is unchanged, the abdominal viscera dysfunction, and each index of correlation does not all change, and sign is without improvement.
Therapeutic outcome: in the 36 routine cases, through treatment in 1-3 month, wherein cure 21 examples, produce effects 8 examples, effective 4 examples, invalid 3 examples, total effective rate reaches 97%.
The result shows, the Chinese medicine for the treatment of seroperitoneum of the present invention, and the patient has extremely significant curative effect to the treatment seroperitoneum.And with low cost, have no toxic and side effects.
Claims (7)
1. a Chinese medicine that is used for the treatment of seroperitoneum is characterized in that, it comprises the raw material components of following weight portion proportioning:
12～18 parts of Semen Coiciss, 12～18 parts of the Radixs Angelicae Dahuricae, 12～18 parts of Cortex Dictamni, 12～18 parts of Pollen Typhaes, 12～18 parts of Radix Angelicae Sinensis, 12～18 parts of Rhizoma Chuanxiongs, 12～18 parts of Radix Paeoniae Rubra, 12～18 parts in Semen Persicae, 12～18 parts of Semen Ziziphi Spinosaes, 12～18 parts of Semen Platycladi, 12～18 parts of Radix Polygalaes, 12～18 parts of Radix Curcumaes, 8～15 parts in Radix Glycyrrhizae.
2. the Chinese medicine that is used for the treatment of seroperitoneum according to claim 1 is characterized in that, it also comprises the raw material components of following weight portion proportioning:
12～18 parts of the Rhizoma Atractylodis Macrocephalaes, 8～15 parts in Poria.
3. the Chinese medicine that is used for the treatment of seroperitoneum according to claim 1 is characterized in that, it is that raw material components by following weight portion proportioning consists of:
13～16 parts of Semen Coiciss, 13～16 parts of the Radixs Angelicae Dahuricae, 13～16 parts of Cortex Dictamni, 13～16 parts of Pollen Typhaes, 13～16 parts of Radix Angelicae Sinensis, 13～16 parts of Rhizoma Chuanxiongs, 13～16 parts of Radix Paeoniae Rubra, 13～16 parts in Semen Persicae, 13～16 parts of Semen Ziziphi Spinosaes, 13～16 parts of Semen Platycladi, 13～16 parts of Radix Polygalaes, 13～16 parts of Radix Curcumaes, 8～12 parts in Radix Glycyrrhizae.
4. the Chinese medicine that is used for the treatment of seroperitoneum according to claim 1 and 2 is characterized in that, it is that raw material components by following weight portion proportioning consists of:
13～16 parts of Semen Coiciss, 13～16 parts of the Radixs Angelicae Dahuricae, 13～16 parts of Cortex Dictamni, 13～16 parts of Pollen Typhaes, 13～16 parts of Radix Angelicae Sinensis, 13～16 parts of Rhizoma Chuanxiongs, 13～16 parts of Radix Paeoniae Rubra, 13～16 parts in Semen Persicae, 13～16 parts of Semen Ziziphi Spinosaes, 13～16 parts of Semen Platycladi, 13～16 parts of Radix Polygalaes, 13～16 parts of Radix Curcumaes, 8～12 parts in Radix Glycyrrhizae, 13～16 parts of the Rhizoma Atractylodis Macrocephalaes, 8～12 parts in Poria.
5. the Chinese medicine that is used for the treatment of seroperitoneum according to claim 3 is characterized in that, it is that raw material components by following weight portion proportioning consists of:
15 parts of Semen Coiciss, 15 parts of the Radixs Angelicae Dahuricae, 15 parts of Cortex Dictamni, 15 parts of Pollen Typhaes, 15 parts of Radix Angelicae Sinensis, 15 parts of Rhizoma Chuanxiongs, 15 parts of Radix Paeoniae Rubra, 15 parts in Semen Persicae, 15 parts of Semen Ziziphi Spinosaes, 15 parts of Semen Platycladi, 15 parts of Radix Polygalaes, 15 parts of Radix Curcumaes, 10 parts in Radix Glycyrrhizae.
6. the Chinese medicine that is used for the treatment of seroperitoneum according to claim 4 is characterized in that, it is that raw material components by following weight portion proportioning consists of:
15 parts of Semen Coiciss, 15 parts of the Radixs Angelicae Dahuricae, 15 parts of Cortex Dictamni, 15 parts of Pollen Typhaes, 15 parts of Radix Angelicae Sinensis, 15 parts of Rhizoma Chuanxiongs, 15 parts of Radix Paeoniae Rubra, 15 parts in Semen Persicae, 15 parts of Semen Ziziphi Spinosaes, 15 parts of Semen Platycladi, 15 parts of Radix Polygalaes, 15 parts of Radix Curcumaes, 10 parts in Radix Glycyrrhizae, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts in Poria.
7. according to claim 1,2,3,4, the 5 or 6 described Chinese medicines that are used for the treatment of seroperitoneum, it is characterized in that, wherein add pharmaceutically acceptable carrier and make and be suitable for medicinal preparation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210116846 CN102626506B (en) | 2012-04-20 | 2012-04-20 | Traditional Chinese medicine for curing seroperitoneum |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210116846 CN102626506B (en) | 2012-04-20 | 2012-04-20 | Traditional Chinese medicine for curing seroperitoneum |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102626506A CN102626506A (en) | 2012-08-08 |
| CN102626506B true CN102626506B (en) | 2013-05-29 |
Family
ID=46585014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210116846 Expired - Fee Related CN102626506B (en) | 2012-04-20 | 2012-04-20 | Traditional Chinese medicine for curing seroperitoneum |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102626506B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105853526A (en) * | 2016-06-03 | 2016-08-17 | 王惠杰 | Traditional Chinese medicine powder for treating joint effusion as well as preparation method and application thereof |
-
2012
- 2012-04-20 CN CN 201210116846 patent/CN102626506B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102626506A (en) | 2012-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101693102A (en) | Traditional Chinese medicine compound for treating diseases of incoordination between the spleen and the stomach and abdominal fullness and distention and preparation method thereof | |
| CN102342992B (en) | Chinese medicinal composition for treating insomnia and preparation method of preparation thereof | |
| CN101422591A (en) | Capsules capable of greatly improving immunity and preparation method thereof | |
| CN101785845B (en) | Traditional Chinese medicine combination and preparation method for intestinal flatulence treatment | |
| CN101972444A (en) | Traditional Chinese medicine composition for treating mastitis and preparation method thereof | |
| CN101766803A (en) | Chinese medicine composite for treating epigastric pain and preparation method thereof | |
| CN104547666A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
| CN104225215A (en) | Traditional Chinese medicine for treating insomnia | |
| CN101773649B (en) | Chinese medicine composition for treating acute abdomen and preparation method thereof | |
| CN102988616B (en) | Chinese medicinal composition for treating anemia | |
| CN102274417A (en) | Chinese patent medicament for treating aplastic anemia | |
| CN102406904B (en) | Traditional Chinese medicine composition for treating vertigo | |
| CN105343865A (en) | Medicine for treating nervous vomiting and preparation method of medicine | |
| CN102626506B (en) | Traditional Chinese medicine for curing seroperitoneum | |
| CN102949698A (en) | Medicine for treating uterine myoma and preparation method thereof | |
| CN103585596B (en) | Traditional Chinese medicine composition for treating migraine | |
| CN1330355C (en) | Chinese medicinal composition for treating ulcer | |
| CN112641911A (en) | Medicine for quickly treating enuresis and premature ejaculation | |
| CN104623605A (en) | Traditional Chinese medicine capable of treating breast cancer | |
| CN103495101B (en) | Traditional Chinese medicine composition for treating stomachache | |
| CN103028063B (en) | Traditional Chinese medicine composition for treating nephropathy | |
| CN104758542A (en) | Traditional Chinese medicine composition for treating uterine prolapse caused by deficiency of kidney qi | |
| CN104524090A (en) | Traditional Chinese medicine preparation for treating sequelae of head injury | |
| CN104189766B (en) | One kind treats schizoid Chinese medicine composition | |
| CN103736066A (en) | Traditional Chinese medicine composition for treating impairment of gastric downbearing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Hao Bingjun Inventor before: Wang Dan |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170830 Address after: 300450 Tianjin Binhai New Area Tanggu Road South, Hu homes ocean ocean natural road to Xibinya garden building 13 -1-3302 Patentee after: Hao Bingjun Address before: 114001, No. 18, 20 workers' street, Shannan Eastern District, Liaoning, Anshan Patentee before: Wang Dan |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130529 Termination date: 20180420 |